Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT03636048
Other study ID # 2018-05-013
Secondary ID
Status Terminated
Phase N/A
First received
Last updated
Start date August 1, 2018
Est. completion date June 1, 2020

Study information

Verified date January 2020
Source Hallym University Kangnam Sacred Heart Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The investigator aimed to compare the effect of anesthesia on overall postoperative outcomes including post-operative pain score and the fetal well-being (heart rate) in patients undergoing transabdominal cervico isthmic cerclage(TCIC). The investigator divided the patients into two groups. The first group was the patients who undergo general anesthesia with postoperative wound patient-controlled analgesia device(PCA) and the second group was the patients who undergo combined spinal-epidural anesthesia(CSE) with postoperative epidural catheter PCA device for pain control.


Description:

Transabdominal cervico isthmic cerclage(TCIC) is performed for the pregnants with Incompetent Internal Os of the Cervix(IIOC) to maintain pregnancy. It is the operation that incise the lower abdomen and ligate the cervix in pelvic cavity. In our center, the surgery was conventionally performed under general anesthesia. Also, for pain control, operator has been inserting a catheter into the incision site and connected the wound PCA. In this way, there were some limitations that the wound PCA could only control the somatic pain and there were significant rates of post-operative nausea and vomiting as common complication of general anesthesia. Thus, the investigator planned to conduct combined spinal-epidural anesthesia(CSE) with postoperative pain control with epidural catheter and compare overall postoperative outcomes with conventional general anesthesia.


Recruitment information / eligibility

Status Terminated
Enrollment 20
Est. completion date June 1, 2020
Est. primary completion date June 1, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 20 Years to 50 Years
Eligibility Inclusion Criteria:

- Patients who undergo TCIC for IIOC and agree to participate in this study.

Exclusion Criteria:

- Hepatic failure

- Chronic kidney disease(>stage III)

- Hypersensitivity, allergic response and/or resistance to drugs used in this study(ex. pethidine, ropivacaine)

- Spinal anesthesia is not possible

- Refuse to participate in the study

- Cannot understand the agreement

- Body weight is under 50 kg or over 100 kg

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Bupivacaine Hcl 0.5% Inj
The patients undergo surgery under spinal anesthesia and a catheter would be inserted into epidural space during the procedure. 0.5% bupivacaine is injected into intrathecal space for spinal anesthesia. For pain control, 0.2% ropivacaine is continuously infused into epidural space postoperatively.
Propofol 10 milligram/ML
The patients undergo surgery under general anesthesia and a catheter would be inserted to abdominal incision site at the end of the operation. Propofol is used for induction of general anesthesia, and sevoflurane is used for maintenance of anesthesia. At the end of the operation, the surgeon inserts wound catheter in the surgical site and connects wound patient-controlled analgesia device filled with 0.5% ropivacaine.

Locations

Country Name City State
Korea, Republic of Kangnam sungshim hospital Seoul

Sponsors (1)

Lead Sponsor Collaborator
Hallym University Kangnam Sacred Heart Hospital

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary Pain score at 24hours after the end of the operation Numerical Rating Score(0-10), 0:no pain, 5:moderate pain, 10:worst pain Assessed by directly asking to the patient, from date of randomization up to postoperative day 3.
Secondary Fetal viability on postoperative day 5 An obstetrician evaluates fetal viability(fetal heart rate) using ultrasonograph. Assessed by ultrasonography, upto postoperative day 5.
See also
  Status Clinical Trial Phase
Recruiting NCT03992534 - The FLIP-1 Study: Vaginal Lactobacillus Supplementation in Women at High Risk of Preterm Birth Phase 1
Completed NCT03305575 - Intrathecal Chloroprocaine vs. Bupivacaine for Cervical Cerclage Phase 4
Withdrawn NCT03077633 - Cerclage for Twins With Short Cervix Phase 2/Phase 3
Recruiting NCT05268640 - Cervical Occlusion Double-level Stitch Application N/A
Completed NCT03311867 - Prolene Versus Ethibond for Cervical Cerclage N/A
Recruiting NCT03837288 - Cervical Cerclage for Singleton Pregnant on Vaginal Progesterone With Progressive Cervical Length Shortening N/A
Not yet recruiting NCT05512052 - Preventing Preterm Birth With a Negative Pressure Cervical Cup: a Feasibility Study Phase 1